Isomorphic Labs raises $2.1B in Series B for AI drug discovery
Demis Hassabis's AI-driven drug discovery startup lands $2.1 billion in new funding...
Deep Dive
A Reddit user, TorturedPoet30, submitted a post.
Key Points
- Isomorphic Labs raised $2.1B in Series B funding, one of the largest AI biotech rounds ever.
- Funds will expand its AlphaFold-based drug discovery platform and internal therapeutic pipeline.
- The investment signals major investor confidence in AI-driven molecular design for pharma R&D.
Why It Matters
Massive capital infusion validates AI-first drug discovery; could speed delivery of novel treatments for major diseases.